AI assistant
Sending…
Vanda Pharmaceuticals Inc. — Director's Dealing 2023
Mar 17, 2023
33390_dirs_2023-03-17_1bc060b8-c1c8-40ae-b5c8-22d35e060d94.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Vanda Pharmaceuticals Inc. (VNDA)
CIK: 0001347178
Period of Report: 2023-03-15
Reporting Person: Honore Tage (Director)
More from Vanda Pharmaceuticals Inc.
Regulatory Filings
2026
Jun 5
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Board/Management Information
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 24
Regulatory Filings
2026
Feb 23
Director's Dealing
2026
Feb 19